Immediate Impact
41 standout
Citing Papers
Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
Prevalence of cancer survivors in the United States
2024 Standout
Works of Katharine Cuff being referenced
Safety and unique pharmacokinetic profile of ARX788, a site-specific ADC, in heavily pretreated patients with HER2-overexpresing solid tumors: Results from two phase 1 clinical trials.
2021
Implementing a nurse-enabled, integrated, shared-care model involving specialists and general practitioners in breast cancer post-treatment follow-up: a study protocol for a phase II randomised controlled trial (the EMINENT trial)
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Katharine Cuff | 113 | 131 | 64 | 68 | 26 | 239 | |
| Tristan Maurina | 107 | 152 | 73 | 118 | 29 | 289 | |
| Guilherme Harada | 146 | 150 | 63 | 86 | 40 | 295 | |
| Natalie Charnley | 86 | 134 | 56 | 64 | 31 | 282 | |
| Josefina Cruz Jurado | 128 | 167 | 45 | 97 | 37 | 258 | |
| W Schmiegel | 114 | 61 | 44 | 57 | 25 | 281 | |
| Shota Fujimoto | 141 | 125 | 47 | 89 | 25 | 293 | |
| Umair Majeed | 141 | 151 | 77 | 89 | 26 | 274 | |
| Eric M. Robinson | 101 | 95 | 56 | 60 | 24 | 224 | |
| Tom Degenhardt | 130 | 85 | 84 | 36 | 32 | 225 | |
| Luigi Cerbone | 116 | 209 | 90 | 102 | 39 | 290 |
All Works
Login with ORCID to disown or claim papers
Loading papers...